Badrilla

Badrilla is a specialized life science company that provides high-performance research tools and reagents specifically designed for the cardiovascular research community. Founded as a spin-out from the University of Leeds, the company excels in the development of site-specific phosphorylation antibodies and recombinant proteins targeting key regulators of cardiac calcium signaling. Their product portfolio is centered on critical proteins such as phospholamban, the ryanodine receptor, and SERCA, which are essential for studying heart contractility and disease mechanisms. Badrilla supports both academic researchers and pharmaceutical drug discovery programs by offering validated assays and reagents that enable precise quantification of protein function and modification. The company is recognized for its technical expertise in cardiac physiology and its commitment to providing tools that meet the rigorous demands of molecular cardiology.